S&T-55 SARCOPENIA AND THE MODIFIED GLASGOW PROGNOSTIC SCORE ARE SIGNIFICANT PREDICTORS OF PATIENT SURVIVAL IN METASTATIC RENAL CELL CARCINOMA PATIENTS RECEIVING FIRST-LINE SUNITINIB TREATMENT | Zendy

AI Assistant Blog Pricing

S&T-55 SARCOPENIA AND THE MODIFIED GLASGOW PROGNOSTIC SCORE ARE SIGNIFICANT PREDICTORS OF PATIENT SURVIVAL IN METASTATIC RENAL CELL CARCINOMA PATIENTS RECEIVING FIRST-LINE SUNITINIB TREATMENT

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.